Olorofim - An Overview
Participant has experienced some other prior or concurrent malignancy inside of 2 several years prior to enrollment with the following exceptions: sufficiently treated localized basal mobile or squamous mobile carcinoma, or curatively dealt with in situ carcinoma of your cervix or breast. Other exceptions might be regarded upon sponsor session.Cont